

Specifications
Abemaciclib 150mg 56 tablets
Indications: CDK4 and CDK6 selective inhibitors for the treatment of advanced or metastatic breast cancer. Mainly used to treat 1) hormone receptor-positive, human epidermal growth factor receptor 2-negative lymph node-positive, high risk of recurrence early breast cancer. 2) hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer.
150mg*56 tablets/box for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
Indications:
Recommended dose: {For reference only, follow doctor's advice}
The recommended dose is 150 mg, twice a day, in combination with aromatase inhibitors such as letrozole or anastrozole.


